Marilyn Kwan to Neoplasm Staging
This is a "connection" page, showing publications Marilyn Kwan has written about Neoplasm Staging.
Connection Strength
1.615
-
Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy. JAMA Netw Open. 2021 11 01; 4(11):e2133861.
Score: 0.182
-
Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. Breast Cancer Res Treat. 2017 02; 161(3):501-513.
Score: 0.129
-
Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors. J Natl Cancer Inst. 2016 Mar; 108(3).
Score: 0.121
-
Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
Score: 0.115
-
Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):32-41.
Score: 0.098
-
Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. Cancer Causes Control. 2012 Sep; 23(9):1587-91.
Score: 0.095
-
Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012 Apr; 132(2):729-39.
Score: 0.092
-
Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205.
Score: 0.088
-
Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
Score: 0.084
-
Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
Score: 0.081
-
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9.
Score: 0.068
-
Social Support and Treatment Delays in Breast Cancer Patients Within an Integrated Health Care System. Psychooncology. 2024 Nov; 33(11):e70025.
Score: 0.056
-
Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev. 2017 07; 26(7):1008-1015.
Score: 0.033
-
Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
Score: 0.033
-
Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. JAMA Oncol. 2017 Mar 01; 3(3):351-357.
Score: 0.033
-
Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors. Breast Cancer Res Treat. 2017 04; 162(3):549-557.
Score: 0.033
-
Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):30-37.
Score: 0.032
-
Postdiagnosis social networks and breast cancer mortality in the After Breast Cancer Pooling Project. Cancer. 2017 Apr 01; 123(7):1228-1237.
Score: 0.032
-
Statins and breast cancer stage and mortality in the Women's Health Initiative. Cancer Causes Control. 2015 Apr; 26(4):529-39.
Score: 0.029
-
Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24.
Score: 0.027
-
Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
Score: 0.027
-
Postdiagnosis cruciferous vegetable consumption and breast cancer outcomes: a report from the After Breast Cancer Pooling Project. Cancer Epidemiol Biomarkers Prev. 2013 Aug; 22(8):1451-6.
Score: 0.025
-
The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis. Sci Rep. 2013; 3:2246.
Score: 0.025
-
Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1115-25.
Score: 0.024
-
Pure and predominantly pure intralymphatic breast carcinoma after neoadjuvant chemotherapy: an unusual and adverse pattern of residual disease. Am J Surg Pathol. 2009 Feb; 33(2):256-63.
Score: 0.019
-
Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2009 Oct; 117(3):653-65.
Score: 0.019
-
Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control. 2008 Dec; 19(10):1319-28.
Score: 0.018